CDH1 and hepatocellular carcinoma: For example, on the one hand, in hepatocellular carcinoma, CtBP1 acts as a transcriptional co-blocker to inhibit cellular expression of E-cadherin, which results in the loss of intercellular adhesion and promotes pathological processes such as epithelial–mesenchymal transition, cancer cell migration and invasion into the stroma.